vs
Side-by-side financial comparison of MEDICAL PROPERTIES TRUST INC (MPW) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
MEDICAL PROPERTIES TRUST INC is the larger business by last-quarter revenue ($270.3M vs $226.2M, roughly 1.2× USANA HEALTH SCIENCES INC). MEDICAL PROPERTIES TRUST INC runs the higher net margin — 6.5% vs 0.1%, a 6.4% gap on every dollar of revenue. On growth, MEDICAL PROPERTIES TRUST INC posted the faster year-over-year revenue change (16.6% vs -10.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (3.1% CAGR vs -0.2%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
MPW vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.3M | $226.2M |
| Net Profit | $17.6M | $180.0K |
| Gross Margin | 95.8% | 78.2% |
| Operating Margin | 9.7% | 1.7% |
| Net Margin | 6.5% | 0.1% |
| Revenue YoY | 16.6% | -10.0% |
| Net Profit YoY | 104.3% | -74.0% |
| EPS (diluted) | $0.03 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.3M | $226.2M | ||
| Q3 25 | $237.5M | $213.7M | ||
| Q2 25 | $240.4M | $235.8M | ||
| Q1 25 | $223.8M | $249.5M | ||
| Q4 24 | $231.8M | $213.6M | ||
| Q3 24 | $225.8M | $200.2M | ||
| Q2 24 | $266.6M | $212.9M | ||
| Q1 24 | $271.3M | — |
| Q4 25 | $17.6M | $180.0K | ||
| Q3 25 | $-77.7M | $-6.5M | ||
| Q2 25 | $-98.4M | $9.7M | ||
| Q1 25 | $-118.3M | $9.4M | ||
| Q4 24 | $-412.3M | $4.5M | ||
| Q3 24 | $-801.2M | $10.6M | ||
| Q2 24 | $-320.6M | $10.4M | ||
| Q1 24 | $-875.6M | — |
| Q4 25 | 95.8% | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | 91.8% | 78.7% | ||
| Q1 25 | 63.6% | 79.0% | ||
| Q4 24 | 90.9% | 82.0% | ||
| Q3 24 | 96.5% | 80.4% | ||
| Q2 24 | 98.4% | 81.1% | ||
| Q1 24 | 84.9% | — |
| Q4 25 | 9.7% | 1.7% | ||
| Q3 25 | -28.0% | 0.6% | ||
| Q2 25 | -36.7% | 7.1% | ||
| Q1 25 | -48.5% | 6.3% | ||
| Q4 24 | -173.7% | 3.8% | ||
| Q3 24 | -350.7% | 7.8% | ||
| Q2 24 | -114.5% | 8.4% | ||
| Q1 24 | -318.6% | — |
| Q4 25 | 6.5% | 0.1% | ||
| Q3 25 | -32.7% | -3.1% | ||
| Q2 25 | -40.9% | 4.1% | ||
| Q1 25 | -52.8% | 3.8% | ||
| Q4 24 | -177.8% | 2.1% | ||
| Q3 24 | -354.8% | 5.3% | ||
| Q2 24 | -120.3% | 4.9% | ||
| Q1 24 | -322.7% | — |
| Q4 25 | $0.03 | $-0.10 | ||
| Q3 25 | $-0.13 | $-0.36 | ||
| Q2 25 | $-0.16 | $0.52 | ||
| Q1 25 | $-0.20 | $0.49 | ||
| Q4 24 | $-0.68 | $0.23 | ||
| Q3 24 | $-1.34 | $0.56 | ||
| Q2 24 | $-0.54 | $0.54 | ||
| Q1 24 | $-1.46 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $540.9M | $158.4M |
| Total DebtLower is stronger | $9.7B | — |
| Stockholders' EquityBook value | $4.6B | — |
| Total Assets | $15.0B | $742.9M |
| Debt / EquityLower = less leverage | 2.11× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $540.9M | $158.4M | ||
| Q3 25 | $396.6M | $145.3M | ||
| Q2 25 | $509.8M | $151.3M | ||
| Q1 25 | $673.5M | $179.6M | ||
| Q4 24 | $332.3M | $181.8M | ||
| Q3 24 | $275.6M | $364.9M | ||
| Q2 24 | $606.5M | $332.4M | ||
| Q1 24 | $224.3M | — |
| Q4 25 | $9.7B | — | ||
| Q3 25 | $9.6B | — | ||
| Q2 25 | $9.6B | — | ||
| Q1 25 | $9.5B | — | ||
| Q4 24 | $8.8B | — | ||
| Q3 24 | $9.2B | — | ||
| Q2 24 | $9.4B | — | ||
| Q1 24 | $10.1B | — |
| Q4 25 | $4.6B | — | ||
| Q3 25 | $4.7B | $528.1M | ||
| Q2 25 | $4.8B | $531.1M | ||
| Q1 25 | $4.8B | $529.8M | ||
| Q4 24 | $4.8B | $532.1M | ||
| Q3 24 | $5.4B | $533.1M | ||
| Q2 24 | $6.2B | $512.2M | ||
| Q1 24 | $6.7B | — |
| Q4 25 | $15.0B | $742.9M | ||
| Q3 25 | $14.9B | $726.6M | ||
| Q2 25 | $15.2B | $734.5M | ||
| Q1 25 | $14.9B | $746.6M | ||
| Q4 24 | $14.3B | $748.2M | ||
| Q3 24 | $15.2B | $671.3M | ||
| Q2 24 | $16.2B | $631.4M | ||
| Q1 24 | $17.3B | — |
| Q4 25 | 2.11× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | 2.00× | — | ||
| Q1 25 | 1.99× | — | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 1.51× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.8M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.8M | — | ||
| Q3 25 | $18.6M | $-2.0M | ||
| Q2 25 | $51.7M | $12.2M | ||
| Q1 25 | $384.0K | $15.5M | ||
| Q4 24 | $245.5M | $5.8M | ||
| Q3 24 | $59.2M | $29.5M | ||
| Q2 24 | $35.3M | $8.0M | ||
| Q1 24 | $74.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-5.2M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $12.7M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $27.1M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | — |
| Q4 25 | 13.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
